Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera
Clinical trial NCT07232290 · RECRUITING
Trial details
- NCT number
- NCT07232290
- Sponsor
- Chengdu Zenitar Biomedical Technology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-23
- Primary completion
- 2027-07-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.